v3.26.1
BUSINESS COMBINATION - Schedule of SLG Valuation (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Mar. 31, 2025
Cash consideration:          
Less: cash acquired   $ (208,014) $ (34,983)    
Liabilities assumed:          
Goodwill   27,617,398   $ 20,842,508  
SLG          
Liabilities assumed:          
Total identified liabilities assumed         $ 10,600,000
Goodwill   $ 14,646,146   $ 14,250,204 $ 14,600,000
SLG | Initial Allocation of Assets and Liabilities          
Cash consideration:          
Cash consideration $ 2,000,000        
Less: cash acquired (34,983)        
Cash consideration, net of cash acquired 1,965,017        
Noncash consideration:          
Accounts receivable in Cycurion owing from SLG 10,814,147        
Noncash consideration 11,323,218        
Total consideration 13,288,235        
Assets acquired:          
Accounts receivable 3,066,581        
Total identified assets acquired 3,066,581        
Liabilities assumed:          
Accounts payable 4,317,052        
Accrued liabilities 10,650        
Payroll liability 40,642        
Factoring liability 2,176,922        
Due to related parties 18,000        
Loans payable 625,222        
Liabilities to Cycurion 2,982,908        
Total identified liabilities assumed 10,171,396        
Net identifiable liabilities assumed (7,104,815)        
Elimination of inter-company balances 2,982,908        
Non-controlling interest (3,464,218)        
Goodwill 13,945,924        
Net assets acquired 13,288,235        
SLG | Initial Allocation of Assets and Liabilities | Common Stock          
Noncash consideration:          
Noncash consideration in equity 254,071        
SLG | Initial Allocation of Assets and Liabilities | Series E Convertible Preferred Stock          
Noncash consideration:          
Noncash consideration in equity 255,000        
SLG | Adjustments          
Noncash consideration:          
Noncash consideration 250,071        
Total consideration 250,071        
Liabilities assumed:          
Accounts payable 222,313        
Accrued liabilities 54,209        
Payroll liability 173,629        
Total identified liabilities assumed 450,151        
Net identifiable liabilities assumed (450,151)        
Goodwill 700,222        
Net assets acquired 250,071        
SLG | Adjustments | Common Stock          
Noncash consideration:          
Noncash consideration in equity 250,071        
SLG | Final Allocation of Assets and Liabilities as of March 31, 2026          
Cash consideration:          
Cash consideration 2,000,000        
Less: cash acquired (34,983)        
Cash consideration, net of cash acquired 1,965,017        
Noncash consideration:          
Accounts receivable in Cycurion owing from SLG 10,814,147        
Noncash consideration 11,573,289        
Total consideration 13,538,306        
Assets acquired:          
Accounts receivable 3,066,581        
Total identified assets acquired 3,066,581        
Liabilities assumed:          
Accounts payable 4,539,365        
Accrued liabilities 64,859        
Payroll liability 214,271        
Factoring liability 2,176,922        
Due to related parties 18,000        
Loans payable 625,222        
Liabilities to Cycurion 2,982,908        
Total identified liabilities assumed 10,621,547        
Net identifiable liabilities assumed (7,554,966)        
Elimination of inter-company balances 2,982,908        
Non-controlling interest (3,464,218)        
Goodwill 14,646,146        
Net assets acquired 13,538,306        
SLG | Final Allocation of Assets and Liabilities as of March 31, 2026 | Common Stock          
Noncash consideration:          
Noncash consideration in equity 504,142        
SLG | Final Allocation of Assets and Liabilities as of March 31, 2026 | Series E Convertible Preferred Stock          
Noncash consideration:          
Noncash consideration in equity $ 255,000